• Press Releases.png

    Press Releases

OmniComm Systems, Inc. Named to 2018 OTCQX Best 50

January 31, 2018

CONTACT :

Kuno van der Post
OmniComm Systems, Inc.
+1.954.473.1254
kvanderpost@omnicomm.com

Fort Lauderdale, FL - OmniComm Systems, Inc. (OTCQX: OMCM), a leading global provider of patient-centric, clinical data management technology, is pleased to announce it has been named to the 2018 OTCQX® Best 50, a ranking of top-performing companies traded on the OTCQX Best Market last year.

OTCQX-Best-50-2018-Logo.pngThe OTCQX Best 50 is an annual ranking of the top 50 U.S. and international companies traded on the OTCQX market. The ranking is calculated based on an equal weighting of one-year total return and average daily dollar volume growth in the previous calendar year. Companies in the 2018 OTCQX Best 50 were ranked based on their performance in 2017. 

“It is an honor to be named to the OTCQX Best 50 this year,” said Stephen Johnson, president and CEO of OmniComm. “We have had another strong year across our products and services. It’s a testament to the hard work and dedication of our employees and the trust our clients place in us.”

For the complete 2018 OTCQX Best 50 ranking, visit: https://otc-ct-otcm-backend-prod.s3.amazonaws.com/files/Best50_2018-1516730454713.pdf

The OTCQX Best Market offers transparent and efficient trading of established, investor-focused U.S. and global companies. To qualify for the OTCQX market, companies must meet high financial standards, follow best practice corporate governance, demonstrate compliance with U.S. securities laws and have a professional third-party sponsor introduction. The companies found on OTCQX are distinguished by the integrity of their operations and diligence with which they convey their qualifications. 

About OmniComm Systems, Inc.
OmniComm Systems, Inc. is a leading strategic software solutions provider to the life sciences industry. OmniComm is dedicated to helping the world’s pharmaceutical, biotechnology, contract research organizations, diagnostic and device firms, and academic medical centers maximize the value of their clinical research investments. Through the use of innovative and progressive technologies, research organizations drive efficiency in clinical development, better manage risks, ensure regulatory compliance and manage their clinical operations performance. OmniComm provides comprehensive solutions for clinical research with an extensive global experience from more than 5,000 clinical trials. Please visit www.omnicomm.com for more information. 

Trademarks
OmniComm, TrialMaster, TrialOne and Promasys are registered trademarks of OmniComm Systems, Inc. Other names may be trademarks of their respective owners.

Topics: Corporate News